您的位置：首页 > 产品中心 > 50-33-9， 保泰松
保泰松
Phenylbutazone
产品价格查看更多规格...
| 产品编号 | 包装单位 | 单价(元) | 国内现货 | 国外库存 | 询价单 |
| 4139670 | 500 mg | 2180 |
产品别名
50-33-9
保泰松
Phenylbutazone
4-Butyl-1,2-diphenyl-3,5-pyrazolidinedione
4-丁基-1,2-二苯基-3,5-吡唑烷二酮
结构式
基本信息
| Empirical Formula【经验(实验)分子式】 | C19H20N2O2 |
| Molecular weight | 308.37 |
| MDL number | MFCD00005500 |
| General description【一般描述】 | Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. |
| Analysis Note【分析说明】 | These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available. |
| Other Notes【其他说明】 | This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis. |
产品性质
| grade【等级】 | certified reference material pharmaceutical secondary standard |
| form【形式】 | powder |
| CofA | current certificate can be downloaded |
| packaging【包装】 | pkg of 500 mg |
| mp | 106-108 ℃ (lit.) |
| pharmacopeia traceability【药典可追溯性】 | traceable to PhEur P1200000 traceable to USP 1531007 |
| storage temp.【储存温度】 | 2-30℃ |
| SMILES string | CCCCC1C(=O)N(N(C1=O)c2ccccc2)c3ccccc3 |
| InChI | 1S/C19H20N2O2/c1-2-3-14-17-18(22)20(15-10-6-4-7-11-15)21(19(17)23)16-12-8-5-9-13-16/h4-13,17H,2-3,14H2,1H3 |
| InChI key | VYMDGNCVAMGZFE-UHFFFAOYSA-N |
安全信息
| Pictograms【象形图】 | GHS06 |
| Signal word【警示用语：】 | Danger |
| Hazard Statements | H301 - H312 + H332 - H315 - H319 - H335 |
| Precautionary Statements | P261 - P280 - P301 + P310 - P302 + P352 + P312 - P304 + P340 + P312 - P305 + P351 + P338 |
| Hazard Classifications【危险分类】 | Acute Tox. 3 Oral - Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 |
| Target Organs【靶器官】 | Respiratory system |
| Storage Class Code【储存分类代码】 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects |
| WGK | WGK 3 |
